🧬 Coming soon: Rapid Microbial Screen.Sterility screening results in hours, not 14 days.Get notified →
PuriLab Analytical
COA/EL-2026-006Verified
Save as PDF

Certificate of Analysis

PuriLab Analytical

Eloralintide 5 mg

EL-2026-006Lot ELO5-1126-A01Analyzed November 17, 2026
Eloralintide 5 mg vial as received

Timeline

Ordered
November 10, 2026
Received
November 16, 2026
Analyzed
November 17, 2026

Sample

Name
Eloralintide 5 mg
Expected
Eloralintide
Amount
1 vial, lyophilized powder

Testing

Client
Emerald Coast Research
Test type
Content & purity
Method
HPLC-UV
Content, how much is in it
5.70mg
Label claim: 5 mg
Purity, how clean it is
>99.9%
Measured, not estimated. Purity is calculated from the full chromatogram shown above, and no impurity peaks were detected above the reporting threshold. Results of 99.95% or higher are reported as >99.9%, as 100% purity cannot be demonstrated analytically.

Chromatogram

HPLC-UV

mAU01002000481216202428Retention time (min)18.73
18.73 min, Eloralintide, >99.9%

Analyst Comments

White lyophilized powder, clear-cap vial labeled Elora 5mg, received sealed.

Analyst Signature

Max Barrett
Lab Director, PuriLab Analytical
Analysis date: November 17, 2026

Verification Code

EL-UAIX-Y2UN
Verify at purilab.org/verify/EL-UAIX-Y2UN

Scan to Verify

EL-UAIX-Y2UN

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analyticaladmin@purilab.org
Page 1 of 1